UNSPSC 51101634: Antienite

This classification denotes an antihelminthic agent with the molecular formula C9H8N2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50Z1JVP72H, chemically known as imidazo(2,1-b)thiazole, 5,6-dihydro-6-(2-thienyl)-, ( -)- but generally known as antienite, which bears US NIH Compound Identifier 170351. European Medicines Agency schedules Antienite in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05529MIG. The term ANTIENITE is an International Non-Proprietary Name.

UNSPSC 51101634 Antienite is a Commodity code reflecting pharmaceutical and medical supply procurement by state and local health agencies, though recent activity under this code tag shows marked divergence between the nominal code classification and actual buying patterns. The two opportunities posted show state and local governments purchasing antibiotic pharmaceuticals (Doxycycline Hyclate and Ciprofloxacin) through piggyback warehouse contracts and emergency-response medical supplies including Naloxone and drug deactivation systems through competitive bid processes. Issuing bodies include state health departments and county health authorities managing inventory for public health response, emergency preparedness, and community health initiatives. Contracts are awarded through Invitation for Bid (IFB) and competitive processes, often structured with initial terms and renewal options, and vendors must meet drug-free workplace certification, E-Verify compliance, and insurance requirements including workers' compensation and general liability coverage.

The Illinois Department of Public Health and Seminole County, Florida represent the recent activity. The Illinois DPH awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026, covering a 12-month initial term with two renewal options for antibiotic tablets supplied through the MMCAP Infuse consortium. Seminole County posted an IFB on June 30, 2026, seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, a two-year initial term, one-year renewal option, and potential FEMA funding that introduces federal compliance requirements including Clean Air Act and Federal Water Pollution Control Act adherence. Both procurements require vendors to absorb shipping and delivery costs and maintain specific insurance and compliance certifications. The code shows episodic activity across select state health departments and county public health systems rather than broad geographic concentration.